Pre-order Enquiry
Request Free Sample
Global Patent Medicine Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
SKU ID : QYR-21980884 | Publishing Date : 07-Nov-2022 | No. of pages : 97
Detailed TOC of Global Patent Medicine Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Patent Medicine Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Product Patents
1.2.3 Process Patents
1.3 Market by Application
1.3.1 Global Patent Medicine Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Adult
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Patent Medicine Market Size (2017-2028)
2.2 Patent Medicine Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Patent Medicine Market Size by Region (2017-2022)
2.4 Global Patent Medicine Market Size Forecast by Region (2023-2028)
2.5 Global Top Patent Medicine Countries Ranking by Market Size
3 Patent Medicine Competitive by Company
3.1 Global Patent Medicine Revenue by Players
3.1.1 Global Patent Medicine Revenue by Players (2017-2022)
3.1.2 Global Patent Medicine Market Share by Players (2017-2022)
3.2 Global Patent Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Patent Medicine Revenue
3.4 Global Patent Medicine Market Concentration Ratio
3.4.1 Global Patent Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Patent Medicine Revenue in 2021
3.5 Global Patent Medicine Key Players Head office and Area Served
3.6 Key Players Patent Medicine Product Solution and Service
3.7 Date of Enter into Patent Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Patent Medicine Breakdown Data by Type
4.1 Global Patent Medicine Historic Revenue by Type (2017-2022)
4.2 Global Patent Medicine Forecasted Revenue by Type (2023-2028)
5 Global Patent Medicine Breakdown Data by Application
5.1 Global Patent Medicine Historic Market Size by Application (2017-2022)
5.2 Global Patent Medicine Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Patent Medicine Revenue by Company (2020-2022)
6.2 North America Patent Medicine Revenue by Type (2017-2028)
6.3 North America Patent Medicine Revenue by Application (2017-2028)
6.4 North America Patent Medicine Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Patent Medicine Revenue by Company (2020-2022)
7.2 Europe Patent Medicine Revenue by Type (2017-2028)
7.3 Europe Patent Medicine Revenue by Application (2017-2028)
7.4 Europe Patent Medicine Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Patent Medicine Revenue by Company (2020-2022)
8.2 Asia Pacific Patent Medicine Revenue by Type (2017-2028)
8.3 Asia Pacific Patent Medicine Revenue by Application (2017-2028)
8.4 Asia Pacific Patent Medicine Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Patent Medicine Revenue by Company (2020-2022)
9.2 Latin America Patent Medicine Revenue by Type (2017-2028)
9.3 Latin America Patent Medicine Revenue by Application (2017-2028)
9.4 Latin America Patent Medicine Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Patent Medicine Revenue by Company (2020-2022)
10.2 Middle East and Africa Patent Medicine Revenue by Type (2017-2028)
10.3 Middle East and Africa Patent Medicine Revenue by Application (2017-2028)
10.4 Middle East and Africa Patent Medicine Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Patent Medicine Products and Services
11.1.4 Pfizer Inc. Patent Medicine Revenue in Patent Medicine Business (2017-2022)
11.1.5 Pfizer Inc. Patent Medicine SWOT Analysis
11.1.6 Pfizer Inc. Recent Developments
11.2 Otsuka Pharmaceutical
11.2.1 Otsuka Pharmaceutical Company Details
11.2.2 Otsuka Pharmaceutical Business Overview
11.2.3 Otsuka Pharmaceutical Patent Medicine Products and Services
11.2.4 Otsuka Pharmaceutical Patent Medicine Revenue in Patent Medicine Business (2017-2022)
11.2.5 Otsuka Pharmaceutical Patent Medicine SWOT Analysis
11.2.6 Otsuka Pharmaceutical Recent Developments
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Patent Medicine Products and Services
11.3.4 Merck Patent Medicine Revenue in Patent Medicine Business (2017-2022)
11.3.5 Merck Patent Medicine SWOT Analysis
11.3.6 Merck Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Patent Medicine Products and Services
11.4.4 Novartis Patent Medicine Revenue in Patent Medicine Business (2017-2022)
11.4.5 Novartis Patent Medicine SWOT Analysis
11.4.6 Novartis Recent Developments
11.5 Sanofi-Aventis
11.5.1 Sanofi-Aventis Company Details
11.5.2 Sanofi-Aventis Business Overview
11.5.3 Sanofi-Aventis Patent Medicine Products and Services
11.5.4 Sanofi-Aventis Patent Medicine Revenue in Patent Medicine Business (2017-2022)
11.5.5 Sanofi-Aventis Patent Medicine SWOT Analysis
11.5.6 Sanofi-Aventis Recent Developments
11.6 Bristol-Myers Squibb Co.
11.6.1 Bristol-Myers Squibb Co. Company Details
11.6.2 Bristol-Myers Squibb Co. Business Overview
11.6.3 Bristol-Myers Squibb Co. Patent Medicine Products and Services
11.6.4 Bristol-Myers Squibb Co. Patent Medicine Revenue in Patent Medicine Business (2017-2022)
11.6.5 Bristol-Myers Squibb Co. Patent Medicine SWOT Analysis
11.6.6 Bristol-Myers Squibb Co. Recent Developments
11.7 GSK
11.7.1 GSK Company Details
11.7.2 GSK Business Overview
11.7.3 GSK Patent Medicine Products and Services
11.7.4 GSK Patent Medicine Revenue in Patent Medicine Business (2017-2022)
11.7.5 GSK Patent Medicine SWOT Analysis
11.7.6 GSK Recent Developments
12 Patent Medicine Market Dynamics
12.1 Patent Medicine Market Trends
12.2 Patent Medicine Market Drivers
12.3 Patent Medicine Market Challenges
12.4 Patent Medicine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Figures, Tables and Charts Available in Global Patent Medicine Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
List of TablesTable 1. Global Patent Medicine Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Product Patents
Table 3. Key Players of Process Patents
Table 4. Global Patent Medicine Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Patent Medicine Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Patent Medicine Revenue by Region (2017-2022) & (US$ Million)
Table 7. Global Patent Medicine Revenue Market Share by Region (2017-2022)
Table 8. Global Patent Medicine Revenue by Players (2017-2022) & (US$ Million)
Table 9. Global Patent Medicine Market Share by Players (2017-2022)
Table 10. Global Top Patent Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patent Medicine as of 2021)
Table 11. Ranking of Global Top Patent Medicine Companies by Revenue (US$ Million) in 2021
Table 12. Global 5 Largest Players Market Share by Patent Medicine Revenue (CR5 and HHI) & (2017-2022)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Patent Medicine Product Solution and Service
Table 15. Date of Key Manufacturers Enter into Patent Medicine Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Patent Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 18. Global Patent Medicine Revenue Market Share by Type (2017-2022)
Table 19. Global Patent Medicine Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 20. Global Patent Medicine Revenue Market Share by Type (2023-2028)
Table 21. Global Patent Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 22. Global Patent Medicine Revenue Market Share by Application (2017-2022)
Table 23. Global Patent Medicine Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 24. Global Patent Medicine Revenue Market Share by Application (2023-2028)
Table 25. North America Patent Medicine Revenue by Company (2020-2022) & (US$ Million)
Table 26. North America Patent Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 27. North America Patent Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 28. North America Patent Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 29. North America Patent Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 30. North America Patent Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 31. North America Patent Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 32. Europe Patent Medicine Revenue by Company (2020-2022) & (US$ Million)
Table 33. Europe Patent Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 34. Europe Patent Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 35. Europe Patent Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 36. Europe Patent Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 37. Europe Patent Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 38. Europe Patent Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 39. Asia Pacific Patent Medicine Revenue by Company (2020-2022) & (US$ Million)
Table 40. Asia Pacific Patent Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 41. Asia Pacific Patent Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 42. Asia Pacific Patent Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 43. Asia Pacific Patent Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 44. Asia Pacific Patent Medicine Revenue by Region (2017-2022) & (US$ Million)
Table 45. Asia Pacific Patent Medicine Revenue by Region (2023-2028) & (US$ Million)
Table 46. Latin America Patent Medicine Revenue by Company (2020-2022) & (US$ Million)
Table 47. Latin America Patent Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 48. Latin America Patent Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 49. Latin America Patent Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 50. Latin America Patent Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 51. Latin America Patent Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 52. Latin America Patent Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 53. Middle East and Africa Patent Medicine Revenue by Company (2020-2022) & (US$ Million)
Table 54. Middle East and Africa Patent Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 55. Middle East and Africa Patent Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Patent Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Patent Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Patent Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Patent Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 60. Pfizer Inc. Company Details
Table 61. Pfizer Inc. Business Overview
Table 62. Pfizer Inc. Patent Medicine Product and Services
Table 63. Pfizer Inc. Patent Medicine Revenue in Patent Medicine Business (2017-2022) & (US$ Million)
Table 64. Pfizer Inc. Patent Medicine SWOT Analysis
Table 65. Pfizer Inc. Recent Developments
Table 66. Otsuka Pharmaceutical Company Details
Table 67. Otsuka Pharmaceutical Business Overview
Table 68. Otsuka Pharmaceutical Patent Medicine Product and Services
Table 69. Otsuka Pharmaceutical Patent Medicine Revenue in Patent Medicine Business (2017-2022) & (US$ Million)
Table 70. Otsuka Pharmaceutical Patent Medicine SWOT Analysis
Table 71. Otsuka Pharmaceutical Recent Developments
Table 72. Merck Company Details
Table 73. Merck Business Overview
Table 74. Merck Patent Medicine Product and Services
Table 75. Merck Patent Medicine Revenue in Patent Medicine Business (2017-2022) & (US$ Million)
Table 76. Merck Patent Medicine SWOT Analysis
Table 77. Merck Recent Developments
Table 78. Novartis Company Details
Table 79. Novartis Business Overview
Table 80. Novartis Patent Medicine Product and Services
Table 81. Novartis Patent Medicine Revenue in Patent Medicine Business (2017-2022) & (US$ Million)
Table 82. Novartis Patent Medicine SWOT Analysis
Table 83. Novartis Recent Developments
Table 84. Sanofi-Aventis Company Details
Table 85. Sanofi-Aventis Business Overview
Table 86. Sanofi-Aventis Patent Medicine Product and Services
Table 87. Sanofi-Aventis Patent Medicine Revenue in Patent Medicine Business (2017-2022) & (US$ Million)
Table 88. Sanofi-Aventis Patent Medicine SWOT Analysis
Table 89. Sanofi-Aventis Recent Developments
Table 90. Bristol-Myers Squibb Co. Company Details
Table 91. Bristol-Myers Squibb Co. Business Overview
Table 92. Bristol-Myers Squibb Co. Patent Medicine Product and Services
Table 93. Bristol-Myers Squibb Co. Patent Medicine Revenue in Patent Medicine Business (2017-2022) & (US$ Million)
Table 94. Bristol-Myers Squibb Co. Patent Medicine SWOT Analysis
Table 95. Bristol-Myers Squibb Co. Recent Developments
Table 96. GSK Company Details
Table 97. GSK Business Overview
Table 98. GSK Patent Medicine Product and Services
Table 99. GSK Patent Medicine Revenue in Patent Medicine Business (2017-2022) & (US$ Million)
Table 100. GSK Patent Medicine SWOT Analysis
Table 101. GSK Recent Developments
Table 102. Patent Medicine Market Trends
Table 103. Patent Medicine Market Drivers
Table 104. Patent Medicine Market Challenges
Table 105. Patent Medicine Market Restraints
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Patent Medicine Sales Market Share by Type: 2021 VS 2028
Figure 2. Product Patents Features
Figure 3. Process Patents Features
Figure 4. Global Patent Medicine Sales Market Share by Application: 2021 VS 2028
Figure 5. Adult Case Studies
Figure 6. Children Case Studies
Figure 7. Patent Medicine Report Years Considered
Figure 8. Global Patent Medicine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 9. Global Patent Medicine Market Size 2017-2028 (US$ Million)
Figure 10. Global Patent Medicine Market Size Market Share by Region: 2021 VS 2028
Figure 11. Global Patent Medicine Revenue Market Share by Region in 2017 VS 2022
Figure 12. Global Top 10 Patent Medicine Countries Ranking by Market Size (US$ Million) in 2021
Figure 13. Global Patent Medicine Market Share by Players in 2021
Figure 14. Global Top Patent Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patent Medicine as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Patent Medicine Revenue in 2021
Figure 16. North America Patent Medicine Revenue Market Share by Company in 2021
Figure 17. North America Patent Medicine Revenue Market Share by Type (2017-2028)
Figure 18. North America Patent Medicine Revenue Market Share by Application (2017-2028)
Figure 19. North America Patent Medicine Revenue Share by Country (2017-2028)
Figure 20. U.S. Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 21. Canada Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 22. Europe Patent Medicine Revenue Market Share by Company in 2021
Figure 23. Europe Patent Medicine Revenue Market Share by Type (2017-2028)
Figure 24. Europe Patent Medicine Revenue Market Share by Application (2017-2028)
Figure 25. Europe Patent Medicine Revenue Share by Country (2017-2028)
Figure 26. Germany Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 27. France Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 28. U.K. Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 29. Italy Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 30. Russia Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 31. Asia Pacific Patent Medicine Revenue Market Share by Company in 2021
Figure 32. Asia Pacific Patent Medicine Revenue Market Share by Type (2017-2028)
Figure 33. Asia Pacific Patent Medicine Revenue Market Share by Application (2017-2028)
Figure 34. Asia Pacific Patent Medicine Revenue Share by Region (2017-2028)
Figure 35. China Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 36. Japan Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 37. South Korea Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 38. India Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 39. Australia Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 40. Taiwan Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 41. Indonesia Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 42. Thailand Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 43. Malaysia Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 44. Philippines Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 45. Vietnam Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 46. Latin America Patent Medicine Revenue Market Share by Company in 2021
Figure 47. Latin America Patent Medicine Revenue Market Share by Type (2017-2028)
Figure 48. Latin America Patent Medicine Revenue Market Share by Application (2017-2028)
Figure 49. Latin America Patent Medicine Revenue Share by Country (2017-2028)
Figure 50. Mexico Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 51. Brazil Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 52. Argentina Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 53. Middle East and Africa Patent Medicine Revenue Market Share by Company in 2021
Figure 54. Middle East and Africa Patent Medicine Revenue Market Share by Type (2017-2028)
Figure 55. Middle East and Africa Patent Medicine Revenue Market Share by Application (2017-2028)
Figure 56. Middle East and Africa Patent Medicine Revenue Share by Country (2017-2028)
Figure 57. Turkey Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 58. Saudi Arabia Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 59. U.A.E Patent Medicine Revenue (2017-2028) & (US$ Million)
Figure 60. Pfizer Inc. Revenue Growth Rate in Patent Medicine Business (2017-2022)
Figure 61. Otsuka Pharmaceutical Revenue Growth Rate in Patent Medicine Business (2017-2022)
Figure 62. Merck Revenue Growth Rate in Patent Medicine Business (2017-2022)
Figure 63. Novartis Revenue Growth Rate in Patent Medicine Business (2017-2022)
Figure 64. Sanofi-Aventis Revenue Growth Rate in Patent Medicine Business (2017-2022)
Figure 65. Bristol-Myers Squibb Co. Revenue Growth Rate in Patent Medicine Business (2017-2022)
Figure 66. GSK Revenue Growth Rate in Patent Medicine Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Keyplayers in Global Patent Medicine Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Pfizer Inc.Otsuka Pharmaceutical
Merck
Novartis
Sanofi-Aventis
Bristol-Myers Squibb Co.
GSK
Request Sample
Request Discount
